Teva Pharmaceutical Industries Ltd. and IVAX Corporation, In the Matter of

Last Updated:
In the Matter of Teva Pharmaceutical Industries Ltd., and IVAX Corporation
FTC Matter/File Number:

051 0214

Docket Number:

C-4155

Enforcement Type:

Part 2 Consents

Case Summary

The consent order allowed Teva to acquire IVAX Corporation, provided the companies sell the rights and assets needed to manufacture and market 15 generic pharmaceutical products. Among the drugs sold were several forms of generic amoxicillin and amoxicillin clavulanate potassium that are widely used in the United States.